Axsome Therapeutics, Inc.
AXSM
Jodie situation report
Axsome Therapeutics, Inc.'s current read is isolated; its market group is not confirming.
No new filing conclusion is available. 0 of 1 group members are active now; 0 filing-linked outsiders are moving with the group, and 0 of 15 directly disclosed connections are confirming.
- Inventory grew more than twice as fast as revenue, increasing the amount of product carried on the balance sheet.
- Six-month cost growth included asset acquisition costs related to AXS-20, partly offset by lower AXS-05 spending.
Invalidation: The isolated read changes if AXSM's group or a disclosed connection begins moving with it.
Who this business touches
The relationships behind AXSM
Customers, suppliers, partners and competitors named in company filings—not inferred from headlines.
Depends on
ABBVAbbVie Inc.competitorMay 4, 2026 ▾
“Among the companies that currently market or are developing therapies that, if approved, our product candidates would potentially compete with include: AbbVie; Amgen Inc.; Avadel Pharmaceuticals plc; Biogen Inc.; Eli Lilly and Company; H.”
AMGNAmgen Inc.competitorMay 4, 2026 ▾
“Among the companies that currently market or are developing therapies that, if approved, our product candidates would potentially compete with include: AbbVie; Amgen Inc.; Avadel Pharmaceuticals plc; Biogen Inc.; Eli Lilly and Company; H.”
Depended on by
DFTXDefinium Therapeutics, Inc.competitorFeb 26, 2026 ▾
“In addition, DT120 ODT would likely face competition from Axsome Therapeutics Inc.’s (“Axsome”) Auvelity, approved for the treatment of MDD.”
Filing peers
Companies whose filings use similar operating language.
Open the three relationships above to see Jodie’s filing proof. Pro unlocks 17 more links, every receipt, and alerts when connected names begin moving. Unlock the full network →
What is moving around it
Live connections
AXSM is currently a Leader in the organic co-movement group CNS Biotech. This group is discovered from market behaviour rather than assigned from an industry taxonomy. 3 filing-linked names are in the relationship map; none is currently confirmed as moving with the group.
This group is retained as the last observed read for AXSM; it is not active in the latest market snapshot.